A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.
about
Genomic approaches to identifying targets for treating β hemoglobinopathiesGenetics of human metabolism: an updateThe genetics of complex cholestatic disordersGenetic determinants of haemolysis in sickle cell anaemia.Early complication in sickle cell anemia children due to A(TA)nTAA polymorphism at the promoter of UGT1A1 geneCombined effects of smoking and bilirubin levels on the risk of lung cancer in Korea: the severance cohort studyGenetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liverNRMT1 knockout mice exhibit phenotypes associated with impaired DNA repair and premature aging.Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.Genetic modifiers of sickle cell diseaseExome-Wide Association Study Identifies New Low-Frequency and Rare UGT1A1 Coding Variants and UGT1A6 Coding Variants Influencing Serum Bilirubin in Elderly Subjects: A Strobe Compliant ArticleBayesian methods for multivariate modeling of pleiotropic SNP associations and genetic risk prediction.Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication.Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients.Applications of high-throughput DNA sequencing to benign hematologyThe search for genetic modifiers of disease severity in the β-hemoglobinopathies.Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.Emerging point-of-care technologies for sickle cell disease screening and monitoring.UGT1A1 (TA)n genotype is not the major risk factor of cholelithiasis in sickle cell disease children.Multiple Testing in the Context of Gene Discovery in Sickle Cell Disease Using Genome-Wide Association Studies.UGT1A1 gene linkage analysis: application of polymorphic markers rs4148326/rs4124874 in the Iranian population.Comment on "Molecular analysis and association with clinical and laboratory manifestations in children with sickle cell anemia".Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease.Is there a role for pharmacogenetics in the treatment of sickle cell disease?Do Alpha Thalassemia, Fetal Hemoglobin, and the UGT1A1 Polymorphism have an Influence on Serum Bilirubin Levels and Cholelithiasis in Patients with Sickle Cell Disease?
P2860
Q26799214-00CCEB82-0FA6-4B66-B304-20FFADB655B0Q26992154-4538D99D-6DE2-42FE-B34B-3B103A9C89E5Q26992279-7216D799-67BA-4727-A1BA-3837C12FD102Q29417116-D7E7C623-F213-440E-A617-E7FB07EA4351Q30448607-4FF2949A-3002-4912-A6F7-7C59FE37E557Q34011326-0669D234-3D42-448E-B58E-4C4DD2A6527CQ34211851-DF1912F8-A9A7-4D73-8C90-C11E3F5DF3BFQ34470316-5BDA0FD3-7011-465B-B709-4B003BC7726EQ35565624-72C8ED68-5594-4D9A-ADC3-2677AC1C475AQ36035471-858DD9FD-29C9-4344-87E7-73379F86B788Q36193715-5FC6FD43-54E0-42C9-8C0D-2F21A9301E17Q36224628-C0960C3A-0325-4876-85EC-F3A56316388CQ36913577-4E91E560-6B9C-4456-9EBD-E3E7E0E5ADDAQ37026772-FCFA6E79-8B25-473E-B626-15D7F6950EA6Q37334703-14931F55-DD31-4B33-A2EA-26A83BF5ABB8Q38048766-7972FEB4-DA02-4482-B52D-D6621A0E3547Q38758451-CDC1E568-59FC-4CA4-995F-A9EDE8904E23Q38804432-73642D04-5FFA-4C11-A72A-DD46C33AC302Q40422332-4187FBEE-644C-4F98-8A2A-A48BE2A83514Q41232448-1E7EFCBC-974E-445D-9B98-856B7140D8CAQ43122090-9B44F9C3-4466-46FF-A427-0D66349204ABQ43133996-D59C630F-37AE-44AE-8593-1343C783C89AQ50061134-F89CE1ED-44D7-4513-8126-763B50DD999CQ52785790-33D73674-C493-4E29-80F1-1140FC9EAADAQ54117269-868D7757-09B5-4EDB-95FE-32040D22B14E
P2860
A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A genome-wide association stud ...... is risk in sickle cell anemia.
@ast
A genome-wide association stud ...... is risk in sickle cell anemia.
@en
A genome-wide association stud ...... is risk in sickle cell anemia.
@nl
type
label
A genome-wide association stud ...... is risk in sickle cell anemia.
@ast
A genome-wide association stud ...... is risk in sickle cell anemia.
@en
A genome-wide association stud ...... is risk in sickle cell anemia.
@nl
prefLabel
A genome-wide association stud ...... is risk in sickle cell anemia.
@ast
A genome-wide association stud ...... is risk in sickle cell anemia.
@en
A genome-wide association stud ...... is risk in sickle cell anemia.
@nl
P2093
P2860
P50
P921
P1433
P1476
A genome-wide association stud ...... is risk in sickle cell anemia.
@en
P2093
Christopher J Bean
Dan E Arking
Emily Barron-Casella
Jacqueline N Milton
James F Casella
Karen Soldano
Marilyn J Telen
Melanie E Garrett
Michael R DeBaun
Nadia Solovieff
P2860
P304
P356
10.1371/JOURNAL.PONE.0034741
P407
P50
P577
2012-04-27T00:00:00Z